News
COR
237.30
-0.55%
-1.32
Weekly Report: what happened at COR last week (0408-0412)?
Weekly Report · 3d ago
CENCORA INC <COR.N>: MIZUHO RAISES TARGET PRICE TO $245 FROM $224
Reuters · 04/11 11:44
Weekly Report: what happened at COR last week (0401-0405)?
Weekly Report · 04/08 09:14
CENCORA INC <COR.N>: BAIRD RAISES TARGET PRICE TO $275 FROM $263
Reuters · 04/05 05:15
TEAMSTERS: AGREEMENT INCLUDES NEW TEAMSTERS HEALTH CARE PLAN, IMPROVEMENTS TO CENCORA'S WAGE PROGRESSION, AND ADDITIONAL PAID TIME OFF
Reuters · 04/03 22:16
BUZZ-'Generally steady' results likely from drug distributors in Q1 2024, Leerink Partners says
Brokerage Leerink Partners says generally steady quarterly results likely from drug distributors in Q1 2024. Raises PT on Cardinal Health's CAH.N and raises PT on Cencora COR to $275 and $600. Sees comfort in prescription trends to support generally steady results for U.S. Drug distributors.
Reuters · 04/03 17:53
CENCORA INC <COR.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $275 FROM $261
Reuters · 04/03 10:37
Weekly Report: what happened at COR last week (0325-0329)?
Weekly Report · 04/01 09:14
Weekly Report: what happened at COR last week (0318-0322)?
Weekly Report · 03/25 09:13
4th Circuit sends West Virginia city's opioid case to state's top court
4th Circuit sends West Virginia city's opioid case to state's top court. The city and county of Huntington and Cabell County sued top drug distributors over the opioid crisis. A lower court rejected their case in 2022. The 4th Circuit sent the case to the state's highest court.
Reuters · 03/18 18:33
Cencora Inc.: Report of proposed sale of securities
Press release · 03/18 18:28
Weekly Report: what happened at COR last week (0311-0315)?
Weekly Report · 03/18 09:13
Judge trims US Justice Department lawsuit against Walmart over opioids
Judge trims US Justice Department lawsuit against Walmart over opioids Judge tosses claims over suspicious orders, 'red flags' Claims that company knowingly filled invalid prescriptions remain. The Justice Department accused Walmart of fueling the opioid epidemic. Walmart says the government's lawsuit is misguided and misapplies the law.
Reuters · 03/11 19:38
Weekly Report: what happened at COR last week (0304-0308)?
Weekly Report · 03/11 09:13
Weekly Report: what happened at COR last week (0226-0301)?
Weekly Report · 03/04 09:13
UPDATE 1-Cencora discloses data breach in cybersecurity incident
Drug distributor Cencora Inc discloses data breach in cybersecurity incident. Some of the data may have contained personal information, company says. The unauthorized activity was detected on Feb. 21, the company said. The company said the incident has had a material impact on its operations.
Reuters · 02/27 23:21
Cencora says hit by cyber attack on its information systems
Cencora says it has learned that data from its information systems had been exfiltrated. Some of the data may contain personal information, the drug distributor said in a filing. Cencora Inc says it was hit by a cyber attack on its information system.
Reuters · 02/27 22:53
Weekly Report: what happened at COR last week (0219-0223)?
Weekly Report · 02/26 09:15
U.S. RESEARCH ROUNDUP-Home Depot, Palo Alto Networks, Wendys
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Home Depot, Palo Alto Networks, Wendys and Wendys among companies with revised targets. Discover Financial Services, Cardinal Health and other companies see analyst downgrades. Some analysts raised their target prices for the companies.
Reuters · 02/21 06:59
Weekly Report: what happened at COR last week (0212-0216)?
Weekly Report · 02/19 09:15
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.